KRAS G12D inhibitor 22
Product Specifications
UNSPSC Description
KRAS G12D inhibitor 22 (compound 6) is a inhibitor of KRAS mutation. KRAS G12D inhibitor 22 has high activity (IC50[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12d-inhibitor-22.html
Solubility
10 mM in DMSO
Smiles
OC1=CC(C=CC(F)=C2C#C)=C2C(C3=NC=C4C(N=C(OCC5(CCC6)N6CC7(C(F)(F)C7)C5)N=C4N8C[C@H]9N[C@H](CC9)C8)=C3F)=C1
Molecular Weight
644.66
References & Citations
[1]Huang Qi, et al. Pyrimidine fused ring compound, preparation method therefor, and use thereof.WO2024061365. 2023-09-22
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162444/KRAS-G12D-inhibitor-22-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162444/
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Monoclonal Antibody to Serine/threonine-protein kinase mTOR (mTOR)